跳至主要内容
临床试验/NCT00114985
NCT00114985已完成2 期

A Phase II Study of Late Rectal Toxicity Following 3-D Conformal External Beam Radiation Therapy Performed Using a Prostate Immobilization Device

Dana-Farber Cancer Institute0 个研究点目标入组 100 人开始时间: 2001年4月最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
入组人数
100
主要终点
Rectal toxicity at six month intervals

研究概览

简要总结

During 3D-conformal external beam radiation therapy treatments for prostate cancer, the prostate gland moves. The purpose of this study is to determine whether the placement of a prostate immobilization device into the rectum during radiation treatments will decrease the risk of rectal bleeding that is sometimes seen as a late effect from radiation.

详细描述

  • MRI using an endorectal coil done prior to treatment for staging.
  • Baseline Quality of Life (QOL) assessment will be completed prior to treatment.
  • Total androgen suppression is initiated and will continue for at least 6 months.
  • Prostate Immobilization Device (PID) placed during the planning session.
  • PID will be placed daily for the first 15 3D external beam radiation treatments.
  • QOL assessment and follow-up will take place every 6 months for 3 years.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
31 Years 至 80 Years(Adult, Older Adult)
性别
Male
接受健康志愿者

入选标准

  • Biopsy proven prostate cancer
  • Clinical Stage T1 - T4
  • Negative bone scan
  • PSA and routine blood work
  • >30 years of age
  • ECOG Performance 0,1, or 2
  • No prior pelvic radiation
  • No pacemaker

排除标准

  • Inflammatory bowel disease (Crohns, or Ulcerative Colitis)
  • Prostatic rectal fistula
  • Stricture of anal canal

结局指标

主要结局

Rectal toxicity at six month intervals

时间窗: 2 years

次要结局

  • urinary symptoms(2 years)
  • Quality of Life(2 years)
  • sexual dysfunction at six month intervals(2 years)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Anthony V. D'Amico, MD, PhD

Principal Investigator

Dana-Farber Cancer Institute

相似试验